SUN PHARMA Share Price, Forecast, News and Quotes - Equitymaster
X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2016 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUN PHARMA Share Price   (SUNP)

REFRESH
Live BSE Quotes Dec 9, 2016 (Close)
Price (Rs)673.00 Open (Rs) 679.95 High (Rs) 682.15 Low (Rs) 671.00
% Change-0.38 Volume 335,028 Value (Rs) 226,544,386 52-Week H/L 898.00 / 572.40
Live NSE Quotes Dec 9, 2016 (Close)
Price (Rs)673.00 Open (Rs) 678.00 High (Rs) 682.80 Low (Rs) 671.25
% Change-0.40 Volume 3,298,719 Value (Rs) 2,230,627,969 52-Week H/L 898.45 / 571.90
Valuation
EPS (Rs)* 30.74 P/E Ratio (x) 21.89 Market Cap (Rs m) 1,619,744.77 P/BV (x) 5.16
  *Trailing 12 months earnings, excluding extraordinary / exceptional items. BSE Sensex | CNX Nifty

Charts
SUN PHARMA Stock Price Chart (Rs) - 1 Year
Loading...
 
Peer Group:
Quote & Graph
     
 S&P BSE SENSEX 
PERIOD
Advanced Charts new


Today's Market

Global Markets Ended on a Positive note(RoundUp)

Barring China (down 0.3%), major global indices closed on a positive note. The US equity markets closed at a record on Friday as the broad indices witnessed its best winning streak since June 2014.

Related Views On News

Sun Pharma: US Segment Shows Signs of Improvement (Quarterly Results Update - Detailed)

Sep 12, 2016

Sun Pharma has announced its 1QFY17 results. The company has reported 22.7% YoY growth in sales and a growth of 266% in the net profits. Here is our analysis of the results.

Sun Pharma: Acquisition synergies start contributing (Quarterly Results Update - Detailed)

Apr 1, 2016

Sun Pharma has announced its 3QFY16 results. Net sales have grown by 2.3% YoY, while net profits surged by 258% YoY. Here is our analysis of the results.

Glenmark: High Costs hit the Bottom line (Quarterly Results Update - Detailed)

Nov 8, 2016

Glenmark has announced its 2QFY16 results. The company has reported 15.7% YoY growth in net sales and 3.5% YoY increase in net profits. Here is our analysis of the results.

Biocon: High Other Income And Licensing Income Drive Growth (Quarterly Results Update - Detailed)

Nov 7, 2016

Biocon has announced its 2QFY17. The company has reported 19.8% YoY growth in net sales and profits of Rs 1.5 bn for the quarter. Here is our analysis of the results.

Biocon: Lower R&D Expenses Help Margin Expansion (Quarterly Results Update - Detailed)

Sep 19, 2016

Biocon has announced its 1QFY17. The company has reported 21.1% YoY growth in total income and 34.6% YoY increase in net profits. Here is our analysis of the results.

More Views on News

Most Popular

Will the Demonetisation Disaster Mean that You Make Money, Or Lose it?(The 5 Minute Wrapup)

Dec 3, 2016

The perceived benefits of demonetisation are actually turning out to be way lower than expected. This, even as its costs mount higher and higher with each passing day.

Can We Finally Say Demonetisation is Dead?(Vivek Kaul's Diary)

Dec 7, 2016

One data point and one clarification from the RBI, essentially tell us that the theories that were being offered in favour of demonetisation were totally wrong.

How to Profit from Gold Prices(Daily Profit Hunter)

Dec 2, 2016

Asad Dossani discusses how you can profit from swings in the price of gold. On Saturday at 10am, he will hold a live question and answer session, where you can learn if the VMS system is right for you.

First Pay Day after Demonetisation - Where is the Cash?(Outside View)

Dec 1, 2016

A hard-working employee has already sacrificed cash on his salary day.

Demonetisation - Long-Term Effects, Part I(Outside View)

Dec 2, 2016

What will be the long term impact from this move on black money and counterfeiting?

More

TRACK SUN PHARMA

  • Track your investment in SUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SUN PHARMA - MYLAN COMPARISON

Compare Company With Charts

COMPARE SUN PHARMA WITH

MARKET STATS